IL17A and periodontitis: All of these results show that SPRC alleviated the progression of periodontitis by inhibiting proinflammatory cytokine (IL-17 and IL-6) expression and promoting anti-inflammatory cytokine (IL-10 and TGF-β) expression in a rat periodontitis model.